Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Novus Therapeutics doses first subject in Phase I trial of OP0201

A bulging tympanic membrane which is typical in a case of acute otitis media. Credit: B. Welleschik.

Go Top